Literature DB >> 11175847

T-cell release of granulysin contributes to host defense in leprosy.

M T Ochoa1, S Stenger, P A Sieling, S Thoma-Uszynski, S Sabet, S Cho, A M Krensky, M Rollinghoff, E Nunes Sarno, A E Burdick, T H Rea, R L Modlin.   

Abstract

A novel mechanism by which T cells contribute to host defense against microbial pathogens is release of the antimicrobial protein granulysin. We investigated the role of granulysin in human infectious disease using leprosy as a model. Granulysin-expressing T cells were detected in cutaneous leprosy lesions at a six-fold greater frequency in patients with the localized tuberculoid as compared with the disseminated lepromatous form of the disease. In contrast, perforin, a cytolytic molecule that colocalizes with granulysin in cytotoxic granules, was expressed at similar levels across the spectrum of disease. Within leprosy lesions, granulysin colocalized in CD4+ T cells and was expressed in CD4+ T-cell lines derived from skin lesions. These CD4+ T-cell lines lysed targets by the granule exocytosis pathway and reduced the viability of mycobacteria in infected targets. Given the broad antimicrobial spectrum of granulysin, these data provide evidence that T-cell release of granulysin contributes to host defense in human infectious disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11175847     DOI: 10.1038/84620

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  53 in total

Review 1.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Amoebapores and NK-lysin, members of a class of structurally distinct antimicrobial and cytolytic peptides from protozoa and mammals: a comparative functional analysis.

Authors:  Heike Bruhn; Beate Riekens; Otto Berninghausen; Matthias Leippe
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

3.  In vivo potential of recombinant granulysin against human tumors.

Authors:  Sameer Al-Wasaby; Diego de Miguel; Adriana Aporta; Javier Naval; Blanca Conde; Luis Martínez-Lostao; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

4.  IL-26 contributes to host defense against intracellular bacteria.

Authors:  Angeline Tilly Dang; Rosane Mb Teles; David I Weiss; Kislay Parvatiyar; Euzenir N Sarno; Maria T Ochoa; Genhong Cheng; Michel Gilliet; Barry R Bloom; Robert L Modlin
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

5.  Transient increase of serum granulysin in a stage IVs neuroblastoma patient during spontaneous regression: case report.

Authors:  Masayuki Nagasawa; Hiroshi Kawamoto; Yoichirou Tsuji; Shuki Mizutani
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

Review 6.  Direct and alternative antimicrobial mechanisms of neutrophil-derived granule proteins.

Authors:  Oliver Soehnlein
Journal:  J Mol Med (Berl)       Date:  2009-07-31       Impact factor: 4.599

7.  Inhalation of recombinant adenovirus expressing granulysin protects mice infected with Mycobacterium tuberculosis.

Authors:  J Ma; J Lu; H Huang; X Teng; M Tian; Q Yu; X Yuan; Y Jing; C Shi; J Li; X Fan
Journal:  Gene Ther       Date:  2015-07-16       Impact factor: 5.250

Review 8.  CD8 T cells and Mycobacterium tuberculosis infection.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  Semin Immunopathol       Date:  2015-04-28       Impact factor: 9.623

9.  Hypoxia promotes Mycobacterium tuberculosis-specific up-regulation of granulysin in human T cells.

Authors:  Sebastian F Zenk; Michael Vollmer; Esra Schercher; Stephanie Kallert; Jan Kubis; Steffen Stenger
Journal:  Med Microbiol Immunol       Date:  2015-11-27       Impact factor: 3.402

Review 10.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.